Alembic Pharma gets USFDA nod for generic ophthalmic solution
News2023-03-30
2 Views
The company has received final approval from the US Food Drug Administration (USFDA) to market Brimonidine Tartrate Ophthalmic Solution, Alembic Pharmaceuticals said in a statement.
Latest News from Moneycontrol.com
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
Building Self-Control Through Mindful Practices
Understanding The Importance Of Financial Habits
